Left Atrial Appendage Electrical Isolation via Bio-photonic Optical Confirmation to Treat Persistent Atrial Fibrillation

Informazioni relative al progetto

LAA-START

ID dell’accordo di sovvenzione: 831117

DOI 10.3030/831117

Progetto concluso

Data della firma CE 14 Dicembre 2018

Data di avvio 1 Gennaio 2019

Data di completamento 31 Marzo 2022

Finanziato da

• Horizon 2020 Framework Programme

Costo totale € 5 012 590,00

Contributo UE € 2 999 998,00

Coordinato da

AURIGEN MEDICAL LIMITED
Ireland

Risultati finali

Websites, patent fillings, videos etc. (1)

Patent application prepared

Patent application prepared

Other (3)

Manufacturing Engineer Appointed

Manufacturing Engineer Appointed

Biostatistician Appointed

Biostatistician Appointed

Clinical Affairs Director Appointed

Clinical Affairs Director Appointed